Polymyalgia Rheumatica

Posts Tagged ‘Rheumatica’

Conclusions:  PMR is associated with a significant imbalance between endothelial injury and repair, which is dependent on the degree of systemic inflammation. Attenuation of inflammation by short‐term corticosteroid therapy might have a role in limiting endothelial fragmentation and promote endothelial repair. (Source: Journal of Internal Medicine)

Polymyalgia Rheumatica Diet Recommendations

This article will outline the starting point of some Polymyalgia Rheumatica diet changes. If you are looking for natural alternatives of treatment for Polymyaglia Rheumatica starting with your diet is a great option. A natural approach will do a good job of getting to the root cause of the problem and not just a so called ‘band-aid’ approach of covering up or masking the symptoms. Polymyalgia rheumatica is classified as an auto-immune disorder and as with other natural approaches to dealing with these types of conditions, dietary changes and modifications can do a world of good.

Why is diet a good place to start for Polymyalgia Rheumatica and other auto-immune disorders? People speculate that often it is common everyday things that are repetitively done could be the trigger for an auto-immune response and put the body into a hyperactive or over sensitive state. The second point is we should start looking at the food that we eat as supplying nutrients and promoting healing in the body and not just something we do three times a day because we are hungry. For centuries before us and still now a days in primitive tribe food is regarded as medicine, but in our modern society maybe because it seems too simple that something that grows on a tree could provide such near miracles, we have lost this perspective.

Read the rest of this entry »

Authors: Kim HA, Lee J, Ha YJ, Kim SH, Lee CH, Choi HJ, Baek HJ, Lim MJ, Park W, Choi S, Hong YS, Lee YH, Koh BR, Suh CH
Abstract
Polymyalgia rheumatica is an inflammatory disease affecting elderly and involving the shoulder and pelvic girdles. No epidemiological study of polymyalgia rheumatica was conducted in Korea. We retrospectively evaluated patients with polymyalgia rheumatica followed up at the rheumatology clinics of 10 tertiary hospitals. In total 51 patients, 36 patients (70.6%) were female. Age at disease onset was 67.4 yr. Twenty-three patients (45.1%) developed polymyalgia rheumatica in winter. Shoulder girdle ache was observed in 45 patients (90%) and elevated erythrocyte sedimentation rate (> 40 mm/h) in 49 patients (96.1%). Initial steroid dose was 23.3 mg/d pred…
MedWorm: Polymyalgia Rheumatica

Conclusions.  Polymyalgia rheumatica is associated with a significant imbalance between endothelial injury and repair, which is dependent on the degree of systemic inflammation. Attenuation of inflammation by short‐term corticosteroid therapy might have a role in limiting endothelial fragmentation and promote endothelial repair. (Source: Journal of Internal Medicine)
MedWorm: Polymyalgia Rheumatica

How to Differentiate Polymyalgia Rheumatica From Temporal Arteritis Or Fibromyalgia

There is a lot of confusion about Polymyalgia Rheumatica (PMR) and its relative similarities with Giant Cell Arteritis and Fibromyalgia. So that you can reference for yourself I have quickly profiled these other diseases in the following paragraphs.

Read the rest of this entry »

Title: Polymyalgia RheumaticaCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 2/15/2012 (Source: MedicineNet Arthritis General)
MedWorm: Polymyalgia Rheumatica

(Source: Arthritis and Rheumatism)
MedWorm: Polymyalgia Rheumatica

The objective of this study was to develop European League Against Rheumatism/American College of Rheumatology classification criteria for polymyalgia rheumatica (PMR). Candidate criteria were evaluated in a 6‐month prospective cohort study of 125 patients with new‐onset PMR and 169 non‐PMR comparison subjects with conditions mimicking PMR. A scoring algorithm was developed based on morning stiffness >45 minutes (2 points), hip pain/limited range of motion (1 point), absence of rheumatoid factor and/or anti–citrullinated protein antibody (2 points), and absence of peripheral joint pain (1 point). A score ≥4 had 68% sensitivity and 78% specificity for discriminating all comparison subjects from PMR. The specificity was higher (88%) for discriminating shoulder conditions from PM…

This study
demonstrated a good clinical and laboratory response to anti-TNF therapy in patients with PMR, with or without glucocorticoid.

Content Type Journal ArticleCategory Case Based ReviewPages 1-5DOI 10.1007/s10067-011-1914-zAuthors
Nádia Emi Aikawa, Rheumatology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Av. Dr. Arnaldo, 455-3o andar-Reumatologia, sala 3190, São Paulo, 01246-903 BrazilRosa Maria Rodrigues Pereira, Rheumatology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Av. Dr. Arnaldo, 455-3o andar-Reumatologia, sala 3190, São Paulo, 01246-903 BrazilLaís Lage, Rheumatology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Av. Dr. Arnaldo, 455-… Read the rest of this entry »

CONCLUSION: Longterm, low-dose GC treatment of PMR is associated with serious adverse events such as osteoporosis, fractures, and arterial hypertension; these adverse events occur mostly after 2 years of treatment.
PMID: 22247343 [PubMed - as supplied by publisher] (Source: J Rheumatol)
MedWorm: Polymyalgia Rheumatica